Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01411930 · ClinicalTrials.gov registry record · Phase 4
Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics
A Phase 4 study, sponsored by Veterans Medical Research Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT01411930 is a Phase 4 study that has completed, run by Veterans Medical Research Foundation. The registered enrollment target is 15 participants.
The verdict
NCT01411930, a Phase 4 study, has completed, sponsored by Veterans Medical Research Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
Antipsychotic medicines used to treat mental illnesses have been associated with effects on blood sugar control. Laboratory studies have shown that certain medications in particular may alter how insulin works. One purpose of this study is determine if antipsychotic medications have immediate effects on insulin action in individuals who do not have a mental disorder, but who have risk factors for diabetes. A second purpose is to demonstrate the feasibility of using volunteers without psychiatric disorders, and who do not take psychiatric medications, as a means for studying antipsychotic metabolic effects.
Interventions
- DRUG Intramuscular olanzapine, aripiprazole
- DRUG Intramuscular aripiprazole, olanzapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-03 |
| Est. Completion | 2011-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01411930
The ClinicalTrials.gov registry entry for NCT01411930 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Veterans Medical Research Foundation, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intramuscular olanzapine, aripiprazole is the first listed.
NCT01411930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01411930 about?
NCT01411930 is a clinical study titled "Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics". Antipsychotic medicines used to treat mental illnesses have been associated with effects on blood sugar control. Laboratory studies have shown that certain medications in particular may alter how insulin works. One purpose of this study is determine if antipsychotic medications have immediate effect...
What is the current status of trial NCT01411930?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2009-03. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01411930?
The interventions under investigation include: Intramuscular olanzapine, aripiprazole (DRUG), Intramuscular aripiprazole, olanzapine (DRUG).
Who is sponsoring clinical trial NCT01411930?
This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.